$3.50
-0.055-1.55%
Last update: Nov 5, 7:05 PM
Prelude Therapeutics Inc (PRLD) Stock Price, Quote, News & History
PRLDNASDAQ
You can purchase shares of Prelude Therapeutics (NASDAQ:PRLD) through any online brokerage.
Other companies in Prelude Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Prelude Therapeutics has a consensus price target of $6.25.
The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $3.5 last updated November 5, 2026 at 7:05 PM EST.
There are no upcoming dividends for Prelude Therapeutics.
Prelude Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Prelude Therapeutics.
Prelude Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to...
